REV-ERB Agonism Improves Liver Pathology in a Mouse Model of NASH
K. Griffett, G. Bedia-Diaz, B. E.-D. M. Elgendy, T. P. Burris
This study shows that activating REV-ERB with SR9009 improves liver health in a mouse NASH model by reducing fibrosis and inflammation.
bioRxiv · Jun 29, 2020Pharmacology & Toxicology